PsyRx CNS Bio-Tech (XTAE:PSRX) Total Liabilities: ₪0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:PSRX PsyRx CNS Bio-Tech Ltd XTAE:PSRX
10 GF Score
Price ₪0.73
! 1 Warning Sign
View Full Analysis

What is PsyRx CNS Bio-Tech Total Liabilities?

PsyRx CNS Bio-Tech XTAE:PSRX +3.09% 10 Total Liabilities is ₪0.00 Mil as of . 20. GuruFocus rates XTAE:PSRX with a GF Score™ of 10/100. The stock has 1 warning sign investors should review.

PsyRx CNS Bio-Tech's Total Liabilities for the quarter that ended in . 20 was ₪0.00 Mil.

PsyRx CNS Bio-Tech Total Liabilities Historical Data

* Premium members only.

The historical data trend for PsyRx CNS Bio-Tech's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PsyRx CNS Bio-Tech Total Liabilities Chart

PsyRx CNS Bio-Tech Annual Data
Trend
Total Liabilities

PsyRx CNS Bio-Tech Semi-Annual Data
Total Liabilities
XTAE:PSRX
10GF Score
PsyRx CNS Bio-Tech Ltd XTAE:PSRX
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PsyRx CNS Bio-Tech Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

PsyRx CNS Bio-Tech's Total Liabilities for the fiscal year that ended in . 20 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=+(+
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+++)
=N/A

Total Liabilities=Total Assets (A: . 20 )-Total Equity (A: . 20 )
=N/A-N/A
=N/A

PsyRx CNS Bio-Tech's Total Liabilities for the quarter that ended in . 20 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=+(+
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+++)
=N/A

Total Liabilities=Total Assets (Q: . 20 )-Total Equity (Q: . 20 )
=N/A-N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ₪0.00 Mil mean?
PsyRx CNS Bio-Tech (XTAE:PSRX) has a Total Liabilities of ₪0.00 Mil as of . 20. The total amount of liabilities as recorded on a company's balance sheet. View historical data for PsyRx CNS Bio-Tech and its competitors.
Is PsyRx CNS Bio-Tech's Total Liabilities too high?
PsyRx CNS Bio-Tech's current Total Liabilities is ₪0.00 Mil. Overall, PsyRx CNS Bio-Tech has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does PsyRx CNS Bio-Tech's Total Liabilities compare to ZTS and UTHR?
PsyRx CNS Bio-Tech's Total Liabilities of ₪0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for PsyRx CNS Bio-Tech and its competitors. PsyRx CNS Bio-Tech's current Total Liabilities is ₪0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PsyRx CNS Bio-Tech stock overvalued right now?
PsyRx CNS Bio-Tech (XTAE:PSRX) has a current Total Liabilities of ₪0.00 Mil. The current Total Liabilities is ₪0.00 Mil. PsyRx CNS Bio-Tech's overall GF Score™ is 10/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For PsyRx CNS Bio-Tech (XTAE:PSRX), the current Total Liabilities is ₪0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PsyRx CNS Bio-Tech Business Description

Address Arik Einstein 3, Herzliya, ISR, 4610301
PsyRx CNS Bio-Tech Ltd Formerly Cannabotech Ltd is engaged in the research and development of cannabis-based drugs. It is a biomedical company focused on the benefits of cannabinoids and medicinal mushrooms, applying the pure power of nature and science to health issues.
10GF Score

Get the complete analysis for XTAE:PSRX

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪0.73
Price